The reactivation of apodopamine β-monooxygenase by vanadyl ions  by Markossian, K.A. et al.
Volume 238, number 2, 401-404 FEB 06402 October 1988 
The reactivation of apodopamine /?-monooxygenase by vanadyl 
ions 
K.A. Markossian, N.A. Paitian and R.M. Nalbandyan 
Institute of Biochemistry, Academy of Sciences, Armenian SSR, Yerevan 375044, USSR 
Received 22 August 1988 
Vanadyl ions may be used for reactivation of apodopamine b-monooxygenase. Maximal activity of the enzyme was 
achieved at a 35&400-fold molar excess of vanadyl ions, whereas for maximal reconstitution with copper, an 88IO-fold 
molar excess of copper was necessary. At higher concentrations of vanadyl as well as of copper, inhibition was observed. 
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1. INTRODUCTION 
Dopamine P-monooxygenase (EC 1.14.17.1) is 
the copper-containing enzyme catalyzing the con- 
version of dopamine to norepinephrine. Copper 
may be removed from dopamine P- 
monooxygenase by using metal chelators, and in 
order to reconstitute the catalytic activity of the en- 
zyme, ionic copper should be added [l-4]. At- 
tempts at reconstituting the apoenzyme using other 
metals, such as Ni(II), Co(II), Mn(II), Zn(II), 
Fe(II), Fe(II1) and Mo(VI), have been reported to 
be unsuccessful [1,5]. 
Here we have investigated the use of vanadyl 
ion, VO(II), in the reactivation of apodopamine ,& 
monooxygenase. There were several reasons for in- 
itiating this study. Firstly, vanadium is considered 
to be an essential trace element participating in the 
regulation (by stimulation or inhibition) of many 
enzymatic processes [6-g]. Secondly, vanadyl ion 
is known to have a high affinity for some proteins 
and enzymes [9,10]. Thirdly, dopamine & 
monooxygenase has also been shown to have some 
catechol oxidase activity [ 11,121, vanadium having 
been reported to stimulate the nonenzymatic ox- 
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idation of catecholamines [ 131. Finally, the auto- 
oxidation of vanadyl to vanadate is accompanied 
by the formation of superoxide radicals, Oi-, 
which are also considered to be intermediates, and 
possibly even cofactors, of dopamine P- 
monooxygenase [ 141. Thus, it would be expected 
that vanadyl ions are able to activate apodopamine 
@-monooxygenase. 
2. MATERIALS AND METHODS 
The soluble form of dopamine Bmonooxygenase was 
purified from chromaffm granules of bovine adrenal medulla 
essentially according to Saxena and Fleming 1151. Preparations 
obtained were electrophoretically homogeneous. Apodopamine 
,&monooxygenase was obtained by incubation of the enzyme 
with 5 mM diethyldithiocarbamate. Excess chelator was re- 
moved by filtration of the mixture through an Amicon PM-30 
membrane in the presence of 0.5 M NaCl, followed by dialysis 
vs 10 mM sodium acetate (pH 6.2). Final purification of the 
apoenzyme was carried out by chromatography on DEAE- 
cellulose under the conditions used for isolation of the 
holoenzyme. 
Copper was assayed chemically with tetraethylthiuram 
disulphide 1161. According to this method, the residual copper 
content in preparations of apodopamine &monooxygenase was 
less than 3% of the value in the holoenzyme. Complete removal 
of diethyldithiocarbamate from the apoenzyme was confirmed 
by paper chromatography. Enzymatic activity of dopamine ,& 
monooxygenase was assayed according to Blackburn et al. [1] 
on a Beckman 0260 oxygen analyzer equipped with a Clark-type 
oxygen electrode and an Omniscribe B-5000 recorder. The reac- 
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tion mixture (2 ml) contained 0.2 M sodium acetate (pH 5.0), 
15 mM tyramine, 20 mM ascorbate, SOyg/ml of catalase and 
the enzyme. To reactivate the apoenzyme, vanadyl or copper 
ions were added to the reaction mixture. The enzyme concentra- 
tion was determined by absorbance at 280 nm using A280 = 12.4 
for a 1% solution [17]. To study the properties of the enzyme 
reconstituted by vanadyl ions, aliquots of VOSO4. 6Hz0 solu- 
tion were added to the apoenzyme dissolved in 0.2 M acetate 
buffer (pH 5.0). Excess vanadyl was removed by ultrafiltration 
of the solution through an Amicon PM-10 membrane. The 
same procedure was used for reconstitution of the enzyme with 
Cu(II). 
EPR spectra were recorded on a Varian E-4 instrument at 
77 K (conditions for EPR spectroscopy: microwave frequency, 
9.11 GHz; microwave power, 10 mW; modulation amplitude, 
10 G). 
Distilled water used for preparation of all stock solutions of 
buffers, proteins and other chemicals was passed through Bio- 
Rex resin (Bio-Rad); all stock solutions were additionally 
treated with this resin. Catalase obtained from bovine liver was 
pretreated with EDTA to remove traces of copper. Stock solu- 
tions (10 mM) of VOS04.6HzO (Wako) were prepared at pH 
3.5 immediately before use. According to the atomic absorption 
data, obtained on an AAA-Sl instrument (Carl Zeiss, Jena), the 
admixture of copper in vanadyl sulphate used was 4 parts per 
10000. 
3. RESULTS AND DISCUSSION 
Although it has been reported that vanadyl ions 
are able to stimulate auto-oxidation of some 
catecholamines [13], we found that vanadyl itself 
does not activate the reaction of monooxygenation 
(hydroxylation) of tyramine. However, when 
vanadyl ions were added to the reaction mixture 
containing apodopamine &monooxygenase rapid 
reactivation of the enzyme occurred (fig.1). Prein- 
cubation of the apoenzyme with vanadyl ions was 
not necessary for reactivation. Maximal reactiva- 
tion was observed at a molar ratio of vanadyl to 
enzyme tetramer of 350-400, whereas with copper 
ions it was achieved at a ratio of copper to enzyme 
tetramer of 8-10. Although vanadyl was less effec- 
tive than copper as an activator of dopamine ,& 
monooxygenase, we found that the maximal level 
of the specific activity of preparations 
reconstituted with vanadyl or copper ions was 
practically equal. Thus, besides copper, vanadium 
is the only metal which is able to reconstitute the 
activity of apodopamine P-monooxygenase. At 
higher concentrations of vanadyl as well as copper 
ions, inhibition of the enzyme activity was ob- 
served (fig.2). Thus, there are certain similarities in 
the effects of both metals on dopamine /3- 
monooxygenase . 
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Fig. 1. Reactivation of apodopamine ,&monooxygenase by 
vanadyl ions. The arrowhead indicates the additions of vanadyl 
sulphate to the reaction mixture containing the apoenzyme 
(0.14 yM). Kinetic traces l-4 were obtained in the presence of 
10, 20, 30 and 40 ,xM vanadyl ions, respectively. 
However, experiments along this line did not 
allow us to draw any conclusions as to the 
mechanisms of the effects observed. Therefore, we 
subsequently investigated the effect of different 
concentrations of vanadyl ions on the activity of 
holodopamine P-monooxygenase. The results ob- 
tained (fig.3) clearly indicate that at low concentra- 
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Fig.2. Dependence of relative activity of dopamine ,8- 
monooxygenase on concentrations of vanadyl (A) and copper 
(B) ions; [apodopamine ,&monooxygenase]: 0.14 ,uM. 
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Fig.3. Inhibition of holodopamine fi-monooxygenase by 
vanadyl ions. Arrowheads indicate additions of (1) 0.15 pM 
holoenzyme, (2) 30 ,uM vanadyl sulphate, (3) 1.2 mM vanadyl 
sulphate. 
tions, vanadyl ions had no effect on the activity of 
copper-containing dopamine P-monooxygenase, 
whereas at high levels, inhibition was observed. It 
may be concluded from these experiments that 
vanadyl ions have low affinities to the enzyme as 
compared with copper ions. To determine the 
number of vanadyl-binding sites, the apoenzyme 
was incubated with a 400-fold molar excess of 
vanadyl for several minutes, unbound and weakly 
bound vanadyl ions being thereafter emoved from 
the reaction mixture by ultrafiltration and ex- 
haustive washing with acetate buffer (pH 5.0). 
Fig.4 shows the EPR spectrum of a preparation 
thus obtained. From a quantitative treatment of 
this spectrum, the preparation contains 4 vanadyl 
ions per enzyme tetramer. It is very attractive to 
suggest hat VO(I1) and Cu(I1) ions are bound to 
the same catalytic sites of the enzyme. However, at 
the present state of knowledge, this suggestion 
would inevitably be speculative. On the other 
hand, it is important to note that during storage (at 
4°C) of the preparation reconstituted with vanadyl 
ions a drop in EPR signal intensity was observed, 
indicating auto-oxidation of vanadyl to vanadate. 
This decrease may be reversed by addition of 
ascorbate which is known to be the cofactor in the 
dopamine fl-monooxygenase reaction [ 181. Thus, 
autooxidation of enzyme-bound vanadyl to 
vanadate is reversed in the ascorbate-containing 
reaction mixture used for determination of the ac- 
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Fig.4. EPR spectrum of apodopamine,%monooxygenase reconstituted by vanadyl ions. Low- and high-field parts of the EPR spectrum 
were recorded separately at 3-times higher gains. 
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tivity of dopamine P-monooxygenase. Hence, the 
ability of vanadyl to reconstitute apodopamine ,& 
monooxygenase may be connected with its reverse 
oxidoreductive transformations as well as being in- 
fluenced by the following conditions which are 
favourable for stabilization of vanadyl ions: bind- 
ing of the ions to the protein moiety; reducing 
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